What Tesamorelin is
Tesamorelin is a synthetic analogue of human GHRH(1-44) with an N-terminal modification that improves stability relative to native GHRH. That stability is the reason it appears in endocrine signalling studies where native GHRH degrades too quickly.
It is supplied as a laboratory research material only and is not a registered therapeutic good in Australia.
What the published research investigates
Published work examines GHRH receptor pharmacology, pituitary signalling models and comparative studies against other secretagogue peptides such as Sermorelin and Ipamorelin.
Read the primary literature via the PubMed link below rather than relying on supplier summaries.
Reconstitution notes
GHRH analogues are typically reconstituted with bacteriostatic water added slowly down the vial wall, then swirled gently — shaking shears the peptide chain.
Record volume, date and lot number so concentration stays traceable to the batch Certificate of Analysis.
Storage & handling in the lab
Lyophilised (freeze-dried) peptides are shipped cold-chain packed and are typically stored at -20°C for long-term storage, or 2-8°C for short periods before reconstitution.
Once reconstituted with bacteriostatic water, vials are generally refrigerated at 2-8°C and protected from light and repeated freeze-thaw cycles.
Every Aussie Peptides vial carries a lot number that maps to a batch Certificate of Analysis, so purity and identity can be recorded alongside your experimental data.
Legal status in Australia
Materials on this site are supplied strictly for in-vitro laboratory research. They are not therapeutic goods, are not approved by the TGA for human use, and are not supplied for human or veterinary consumption.
Purchasers must be 18 or over and are responsible for handling, storing and disposing of research materials in line with their institution's requirements and applicable Australian law.
Nothing on this page is medical advice, a dosing protocol, or a claim of therapeutic benefit. It summarises what the published research literature investigates.
Common questions
Both are GHRH-based peptides, but Tesamorelin carries an N-terminal modification that increases stability. Comparative pharmacology between the two is a common subject in the literature.
It can be supplied as a laboratory research chemical for in-vitro use. It is not TGA-approved for human use and is not sold for human or veterinary consumption.
Yes — every lot has a batch-specific CoA with the HPLC chromatogram and mass-spec identity confirmation, available on request or via our batch lookup tool.